TG Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results

NEXT STORY
Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries
PREV STORY
OKYO Pharma Limited Announces final audited results for the year ended 31 March 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Jordan Barnett, M.D., is Honored by the American Health Council for Best in Medicine

NEW YORK, July 06, 2017 (GLOBE NEWSWIRE) -- With a diverse educational background in ...

author_avatar
NASDAQ Market News

VBL Therapeutics Announces Proposed Public Offering of 2.5 Million Shares of Ordinary Shares

TEL AVIV, Israel, Nov. 16, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage ...

author_avatar
NASDAQ Market News

Zenith Capital Closes $5.7 Million Private Placement

This press release is not for dissemination in the United States or through US ...

author_avatar
NASDAQ Market News